All Posts
M-A | Ionizing radiation and cardiovascular disease
14 Mar, 2023 | 13:49h | UTCIonising radiation and cardiovascular disease: systematic review and meta-analysis – The BMJ
News Release: Low dose radiation linked to increased lifetime risk of heart disease – BMJ Newsroom
Review | Orthostatic tachycardia after covid-19
14 Mar, 2023 | 13:48h | UTCOrthostatic tachycardia after covid-19 – The BMJ
Commentary: Key steps for diagnosis and management of orthostatic tachycardia after COVID-19 – News Medical
RCT | Three-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis
14 Mar, 2023 | 13:47h | UTCThree-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis – Journal of the American College of Cardiology (link to abstract – $ for full-text)
News Release: Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years – American College of Cardiology
Commentary on Twitter
#ACC23/#WCCardio #JACC LBCT SimPub: Data from the Evolut Low Risk trial demonstrated that #TAVR at 3 years showed durable benefits compared with surgery with respect to all-cause mortality or disabling stroke. https://t.co/PtEEFI1P1t#vhdAS #SAVR #CardioTwitter @kashishgoelmd pic.twitter.com/x0milxBGxO
— JACC Journals (@JACCJournals) March 5, 2023
Mortality rates and clinical manifestations of severe hypothyroidism in the ICU: a French multicenter cohort study
14 Mar, 2023 | 13:44h | UTCSummary: This article presents the findings of a retrospective multicenter cohort study conducted over 18 years in 32 French ICUs to investigate severe hypothyroidism (SH) requiring ICU admission.
The study included 82 patients with SH, with thyroiditis and thyroidectomy being the primary causes, and levothyroxine discontinuation, sepsis, and amiodarone-related hypothyroidism being the most frequent triggers.
Patients with SH presented with various clinical symptoms, including hypothermia, hemodynamic failure, and coma, with in-ICU and 6-month mortality rates being 26% and 39%, respectively. The study also found that patients with hemodynamic and respiratory failure on admission to the ICU had a higher likelihood of mortality.
Levothyroxine replacement was provided to all patients, but the administration route and loading dose varied. The authors recommend early diagnosis, prompt levothyroxine administration, and close monitoring of cardiac and hemodynamic parameters for SH patients admitted to the ICU.
SR | Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how
14 Mar, 2023 | 13:46h | UTC
Risk factors for Carbapenem-Resistant Enterobacterales infections: a matched case-control study
14 Mar, 2023 | 13:43h | UTCSummary: The study aimed to investigate risk factors for infections caused by carbapenem-resistant Enterobacterales (CRE) and identify variables that increase the probability of CRE infection among admitted patients in hospitals with high CRE incidence.
The study was performed in 50 hospitals in Southern Europe from March 2016 to November 2018 and included patients with complicated urinary tract infection, complicated intraabdominal infection, pneumonia, or bacteremia from other sources due to CRE. Control groups were patients with infection caused by carbapenem-susceptible Enterobacterales and non-infected patients, matched according to the same criteria as the CRE group (type of infection, ward, and duration of hospital admission).
The results showed that the main risk factors for CRE infections were previous colonization with CRE, use of urinary catheters, and exposure to broad-spectrum antibiotics.
The study’s findings offer evidence to inform decisions about preventive measures and empirical treatment for patients with suspected CRE infections. Additionally, the study can guide the efficient design of future randomized trials focusing on high-risk patients.
Related:
RCT | Colistin monotherapy vs. combination therapy for carbapenem-resistant organisms
Ultrasound-guided nerve blocks | Suggested procedural guidelines for emergency physicians
14 Mar, 2023 | 13:41h | UTC
Review | Pathogenesis, epidemiology and control of Group A Streptococcus infection
14 Mar, 2023 | 13:38h | UTC
Commentary on Twitter
NEW📢🎉Pathogenesis, epidemiology and control of Group A Streptococcus infectionhttps://t.co/XFSKQrTe1P
Brouwer & co. summarize the epidemiological and clinical features of Group A Streptococcus infection, and the molecular mechanisms of GAS virulence and drug resistance. pic.twitter.com/qm23YgnKlg
— Nature Reviews Microbiology (@NatureRevMicro) March 10, 2023
International society of sports nutrition position stand: energy drinks and energy shots
14 Mar, 2023 | 13:39h | UTC
Burden, trends, and inequalities of heart failure globally, 1990 to 2019
14 Mar, 2023 | 13:35h | UTC
Podcast and Brief Review | TIA/Stroke pearls for the hospitalist
14 Mar, 2023 | 13:36h | UTC#385 TIA/Stroke for the Hospitalist featuring Dr. Karima Benameur – The Curbsiders
Adolescent substance use | Objective assessment with hair analysis nearly doubled the estimated prevalence based on self-reported data
14 Mar, 2023 | 13:34h | UTCNews Release: Hair analysis shows child drug use could be twice as high as we think – Taylor & Francis Group
Press release | New technique reduces postoperative complications in prostate cancer surgery
14 Mar, 2023 | 13:33h | UTC
Evidence for harmful cardiovascular effects of ambient ozone: Insights from a multi-city time-series study in China
14 Mar, 2023 | 13:32h | UTCOzone pollution and hospital admissions for cardiovascular events – European Heart Journal
News Release: Ozone pollution is linked with increased hospitalizations for cardiovascular disease – European Society of Cardiology
Perspective | Embracing complexity in sepsis
14 Mar, 2023 | 13:31h | UTCEmbracing complexity in sepsis – Critical Care
Feasibility and efficacy of microwave ablation in the treatment of papillary thyroid microcarcinoma: a prospective cohort study
14 Mar, 2023 | 13:30h | UTCMicrowave Ablation for Papillary Thyroid Microcarcinoma with and without US-detected Capsule Invasion: A Multicenter Prospective Cohort Study – Radiology (link to abstract – $ for full-text)
Retrospective Cohort | Arrhythmogenic cardiotoxicity associated with contemporary treatments of lymphoproliferative disorders
14 Mar, 2023 | 13:27h | UTC
Review | Role of precision medicine in obstructive sleep apnea
14 Mar, 2023 | 13:28h | UTCRole of precision medicine in obstructive sleep apnoea – BMJ Medicine
Commentary on Twitter
#Review: Role of precision medicine in obstructive sleep #apnoea ▶️https://t.co/OnxOHR2F6T#BMJMedicine pic.twitter.com/GUT3dKkfvL
— BMJMedicine (@BMJMedicine) March 9, 2023
Perspective | How I prescribe prolonged intermittent renal replacement therapy
14 Mar, 2023 | 13:26h | UTCHow I prescribe prolonged intermittent renal replacement therapy – Critical Care
SR | Do treatment effects in randomized trials differ when using active placebo compared to standard placebo?
14 Mar, 2023 | 13:25h | UTC
Commentary on Twitter
🧵 In our recent #Cochrane Review, we look at the impact of using #ActivePlacebo control versus standard placebo in randomised drug trials. https://t.co/7VwTOSRKxF#Blinding #Unblinding #Placebo #Bias @cochranemthds @AsgerPaludan @ChrisPaWer
1/10
— David Laursen (@LaursenDavid) March 8, 2023
Dose‐escalated radiotherapy for clinically localized and locally advanced prostate cancer
14 Mar, 2023 | 13:21h | UTC
SR | Parathyroidectomy for adults with primary hyperparathyroidism
14 Mar, 2023 | 13:22h | UTCParathyroidectomy for adults with primary hyperparathyroidism – Cochrane Library
Summary: Parathyroidectomy for adults with primary hyperparathyroidism – Cochrane Library
Review | Guideline-based management of acute respiratory failure and acute respiratory distress syndrome
14 Mar, 2023 | 13:17h | UTC
Findings of daily point-of-care ultrasound assessment of CVC-related thrombosis in critically ill patients
14 Mar, 2023 | 13:19h | UTCDaily point-of-care ultrasound-assessment of central venous catheter-related thrombosis in critically ill patients: a prospective multicenter study – Intensive Care Medicine (free for a limited period)
Commentary on Twitter
#POCUS assessment of CVC related thrombosis in #ICU
➡️ common (16.9%) mostly in IJV
➡️ can occur soon: 12% 1st day, 82% in 7 days
➡️ ⅓ small, ⅓ extensive
➡️ often nonprogressive, rarely occlusive; gradual ⬇️ after removal
⬆️ #ICU LoS but = mortality
🖇️ https://t.co/AyBrMOTyBb pic.twitter.com/qMmxuNYdvT— Intensive Care Medicine (@yourICM) March 10, 2023
CDC recommends HBV screening at least once in a lifetime for all adults aged ≥18 years
13 Mar, 2023 | 15:14h | UTCSummary: The Centers for Disease Control and Prevention (CDC) has issued new recommendations for screening and testing for hepatitis B virus (HBV) infection in the US.
The recommendations include screening for HBV infection at least once in a lifetime for adults aged ≥18 years and more frequent testing for persons at increased risk for HBV infection. The risk groups include:
- Persons incarcerated or formerly incarcerated in jail, prison, or other detention settings.
- Persons with a history of sexually transmitted infections or multiple sex partners.
- Persons with a history of hepatitis C virus infection.
The CDC recommends using the triple panel (HBsAg, anti-HBs, and total anti-HBc) for initial screening to help identify persons who have an active HBV infection, have resolved infection and might be susceptible to reactivation, are susceptible and need vaccination, or are vaccinated.
Commentaries:
Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination – JAMA
CDC recommends hepatitis B screening for all adults – CIDRAP
CDC Recommends Universal Screening for Hepatitis B Virus – HCP Live
Commentary on Twitter
CDC recommends that all adults get tested for #HepatitisB at least once in their life. Ask your doctor if you’ve been tested. Learn more: https://t.co/kLBZyQYZtQ @CDCMMWR pic.twitter.com/EBkQ9s4MsQ
— CDC (@CDCgov) March 9, 2023


